2020;395:1054 -62. 20. Lee LYW, Cazier JB, Starkey T, et al. COVID -19 mortality in patients wi th cancer on chemotherapy or other anticancer treatments: a prospective cohort study. Lancet. 2020;395:1919 -26. 21. Garassino MC, Whisenant JG, Huang LC, et al. COVID -19 in patients with thoracic malignancies (TERAVOLT): first results of an international, regi stry-based, cohort study. Lancet Oncol. 2020;21:914 -22. 22. Kuderer NM, Choueiri TK, Shah DP, et al. Clinical impact of COVID -19 on patients with cancer (CCC19): a cohort study. Lancet. 2020;395:1907 -18. 23. Scarfo L, Chatzikonstantinou T, Rigolin GM, et al. COVID -19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL Campus. Leukemia. 2020;34:2354 -63. 24. Pinato DJ, Lee AJX, Biello F, et al. Presenting features and early mortali ty from SARS -CoV-2 infection in cancer patients during the initial stage of the COVID -19 pandemic in Europe. Cancers (Basel). 2020;12:1841 . 25. Lara OD, O'Cearbhaill RE, Smith MJ, et al. COVID -19 outcomes of patients with gynecologic cancer in New York City. Cancer. 2020. 26. Grivas P, Warner J, Shyr Y, et al. Assessment of clinical and laboratory prognostic factors in patients with cancer and SARS -CoV-2 infection: The COVID -19 and Cancer Consortium (CCC19). Ann Oncol. 2020; 31:S1202. 27. Wise -Draper T, Desai A, Elkrief A, et al. Systemic cancer treatment -related outcomes in patients with SARS -CoV-2 infection: A CCC19 registry analysis. Ann Oncol. 2020; 31:S120 1. Version number: 6.0, 27 December 2021 44 of 49 28. Walsh EE, Frenck RW, Falsey AR, et al. Safety and immunogenicity of two RNA - based Covid -19 vaccine candidates. N Eng J Med. 2020. 29. Jackson LA, Anderson EJ, Rouphael NG, et al. An mRNA Vaccine against SARS - CoV-2 - preliminary report. N Eng J Med. 2020. 30. Andersons EJ, Rouphael NG, Widge AT, et al. Safety and immunogenicity of SARS - CoV-2 mRNA -1273 vaccine in older Adults. N Eng J Med. 2020. 31. Widge AT, Rouphael NG, Jackson LA, et al. Durability of responses after SARS -CoV- mRNA 1273 vaccination . N Eng J Med.